On November 25, Matt Powers, managing partner of Powers Advisory Group, joined CNBC’s ‘Squawk Box’ to discuss what to make of recent volatility and why he believes that value will start to pick up. Regarding the signs of market capitulation observed last week, it was acknowledged that the current signs might differ from historical norms. Powers announced his firm’s decision to upgrade equities to overweight at the close of the prior week, expressing an expectation for new all-time highs and a good chance to surpass 7,000 for the S&P 500 index by the end of the year. This optimistic outlook was supported by several factors. First, the group’s internal sentiment model, which aggregates key positioning and sentiment data, had registered extreme pessimism. Second, they observed a significant spike in inverse ETF volume, a measure they use to track retail capitulation. This volume reached its highest level in two years, a pattern that has historically marked near-term market bottoms. Third, they pointed to the level of hidden pain in the recent pullback; while the main index was down just over 5% peak to trough, the median stock was down more than 16% from its 52-week high. Historically, this amount of pain in individual stocks suggests a more severe correction, closer to 10%, for the overall index. Combining these technical and sentiment signals with positive seasonal trends, Powers concluded that the market is set up for a very strong end of the year.
Powers, while finding the strong performance of both the Equal Weight S&P and the Russell 2000 encouraging, injected a note of caution regarding the latter. He characterized being long the Russell 2000 as very much a rates bet, explaining that the Russell is the subsegment of the market most sensitive to interest rate movements. Given that the 10-year yield was down to 4%, holding a long position in the Russell is a bet that rates will continue to fall along a glide path while economic growth remains robust. The guest described this as a needle that needs to be threaded, and while the one-day performance was healthy, the index was not where they would currently focus their investments.
That being said, we’re here with a list of the 10 most promising stocks with huge upside potential.
Our Methodology
We sifted through the Finviz stock screener to compile a list of the most promising stocks that were the most popular among elite hedge funds. We then picked 10 stocks with high upside potential of over 40%. The stocks are ranked in ascending order of their upside potential. We have also added the hedge fund sentiment for each stock, as of Q2 2025, which was sourced from Insider Monkey’s database.
Note: All data was sourced on November 25.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
10 Most Promising Stocks with Huge Upside Potential
10. Peloton Interactive Inc. (NASDAQ:PTON)
Number of Hedge Fund Holders: 53
Average Upside Potential as of November 25: 44.66%
Peloton Interactive Inc. (NASDAQ:PTON) is one of the most promising stocks with huge upside potential. On November 20, Citi analyst Ronald Josey cut the price target on Peloton to $8.25 from $9.50 while keeping a Neutral rating on the shares after the company posted its FQ1 2026 earnings report. The firm also lowered its full-year subscriber forecast for Peloton by 3% due to a rise in customer turnover.
Peloton’s total revenue for FQ1 reached $551 million, comprising $152 million from Connected Fitness products and $398 million from subscription revenue. While this revenue was a decline of 6.01% year-over-year, it was still $9.72 million higher than Street estimates. The company’s EPS also surpassed guidance by $0.05 and totaled $0.06. Peloton’s full-year revenue guidance remains unchanged at $2.4 to $2.5 billion.
The company’s Connected Fitness paid subscriptions totaled 2.732 million in the said quarter, which was a 6% decrease from the year-ago period due to challenges in maintaining subscriber growth. The average net monthly churn, however, improved to 1.6%, better by 0.2% year-over-year. Despite the subscription decrease, the company experienced a decline of 5% in Connected Fitness products revenue due to lower equipment sales and deliveries.
Peloton Interactive Inc. (NASDAQ:PTON) provides fitness and wellness products and services in North America and internationally. The company offers several connected fitness products, such as the Peloton Bike, Peloton Bike+, Peloton Tread, Peloton Tread+, and Peloton Row.
9. Coinbase Global Inc. (NASDAQ:COIN)
Number of Hedge Fund Holders: 87
Average Upside Potential as of November 25: 57.41%
Coinbase Global Inc. (NASDAQ:COIN) is one of the most promising stocks with huge upside potential. On November 25, Argus analyst Kevin Heal downgraded Coinbase to Hold from Buy with no price target. The company stands as the top cryptocurrency trading platform, and its dollar-backed stablecoin, USDC (which is the world’s second-largest), is maintaining strong growth. However, Heal noted a significant valuation issue: the stock is currently trading at 39x its expected forward earnings, substantially higher than the 24x to 27x multiples observed for competing exchanges.
In other news, the company’s Q3 2025 earnings report disclosed that Coinbase Global experienced a total trading volume of $295 billion in the quarter, which was sequentially up 24%. Consumer trading volume specifically grew 37% to $59 billion, outperforming the US spot markets.
The company reported a total revenue of $1.9 billion in Q3, which was a sequential rise of 25%. Net income stood at $433 million, fueled by both transaction and subscription revenues. Transaction revenue reached $1.0 billion, up 37%, with consumer transaction revenue at $844 million, up 30%. Furthermore, the company successfully grew its Subscription and Services revenue to $747 million, an increase of 14%, contributing to overall financial growth.
Coinbase Global Inc. (NASDAQ:COIN) operates a platform for crypto assets in the US and internationally.
8. Rubrik Inc. (NYSE:RBRK)
Number of Hedge Fund Holders: 52
Average Upside Potential as of November 25: 67.66%
Rubrik Inc. (NYSE:RBRK) is one of the most promising stocks with huge upside potential. On November 18, Rubrik announced two new offerings: Rubrik Intelligent Business Recovery for Microsoft 365 and DevOps Protection for Azure DevOps & GitHub. The goal of these services is to provide enterprises with intelligent recovery following a cyberattack or significant outage for swift data recovery and the rapid restoration of mission-critical functions for operational resilience.
The Intelligent Business Recovery for Microsoft 365 is an advancement over traditional data recovery methods, which often lack business context and solely focus on single workloads or time-based recovery. Current solutions also struggle to provide visibility into where critical data resides across Microsoft 365 applications. This new Rubrik offering introduces automated, business-aware recovery to restore critical users and their associated data across applications.
DevOps Protection for Azure DevOps & GitHub addresses the critical need to safeguard the vast amount of intellectual property and artifacts, including source code, Infrastructure as Code/IaC, and AI/ML pipelines, housed within modern DevOps platforms. These environments are increasingly becoming a prime target for cyberattacks, and native platform security is often insufficient against modern threats, exacerbated by the introduction of new vulnerabilities through widespread AI agents. Rubrik DevOps Protection aims to close these gaps by providing a single, trusted platform to secure the entire software and AI development lifecycle.
Rubrik Inc. (NYSE:RBRK) provides data security solutions to individuals and businesses worldwide. It serves financial, retail, trade, transportation, energy, industrial, healthcare & life science, education, technology, media, communications, services, and public sectors.
7. Caesars Entertainment Inc. (NASDAQ: CZR)
Number of Hedge Fund Holders: 61
Average Upside Potential as of November 25: 68.11%
Caesars Entertainment Inc. (NASDAQ:CZR) is one of the most promising stocks with huge upside potential. On November 21, Citi initiated coverage of Caesars with a Neutral rating and $23 price target. This sentiment surrounding the Neutral rating was announced as the firm believes that investors are concerned that Caesars Entertainment is replacing its high-margin strategy with more aggressive promotions.
In its Q3 2025 earnings report, which was released earlier, Caesars Entertainment disclosed achieving consolidated net revenues of $2.87 billion, which was both a modest decline of 0.17% year-over-year and also $25.34 million below guidance.
The company’s Regional Segment saw a net revenue growth of 6% year-over-year, driven by strong returns in Danville and New Orleans, and same-store growth from strategic reinvestment in the Caesars Rewards customer database. The Digital Segment reported net revenue of $311 million due to strong core volume growth in both sports and iCasino, with iCasino net revenue growing 29% due to increased volume and average monthly active users.
Caesars Entertainment Inc. (NASDAQ:CZR) operates as a gaming and hospitality company. The company owns, leases, brands, or manages domestic properties in 18 states with slot machines, video lottery terminals, and e-tables, and hotel rooms, as well as table games, including poker.
6. Flutter Entertainment (NYSE:FLUT)
Number of Hedge Fund Holders: 87
Average Upside Potential as of November 25: 68.89%
Flutter Entertainment (NYSE:FLUT) is one of the most promising stocks with huge upside potential. On November 24, HSBC upgraded Flutter Entertainment to Buy from Hold with a price target of $228, down from $265. HSBC has identified a buying opportunity for the shares after the recent price decline. The firm reassured that although the US gaming market is maturing and slowing, the perceived risks in both the US and the UK appear to be overstated and already reflected in the current share price.
In its Q3 2025 earnings call, Flutter Entertainment reported earnings $1.64 per share, which was $1.14 higher than Wall Street estimates. The company was also able to generate revenue $12.75 million above guidance, totalling $3.79 billion and growing 16.84% year-over-year.
The company maintained its position as the number one online operator in both the US sportsbook and iGaming markets. US Revenue increased by 9% year-over-year. This growth was fueled by impressive iGaming growth of 44%, which offset a 5% decline in sportsbook revenue. The sportsbook faced challenges from customer-friendly sports results and heightened competitive intensity, particularly increased competitor generosity at the start of the NFL season. Despite this, the company achieved a 47% NGR market share in September.
Flutter Entertainment (NYSE:FLUT) operates as a sports betting and gaming company in the US, the UK, Ireland, Australia, Italy, and internationally.
5. Monday.com Ltd. (NASDAQ:MNDY)
Number of Hedge Fund Holders: 67
Average Upside Potential as of November 25: 75.94%
Monday.com Ltd. (NASDAQ:MNDY) is one of the most promising stocks with huge upside potential. On November 11, UBS analyst Taylor McGinnis lowered the firm’s price target on Monday.com to $200 from $215 and kept a Neutral rating on the shares. This sentiment was announced as McGinnis noted that Monday.com’s reduced Q4 2025 guidance is raising concerns about the company’s growth trajectory for 2026.
Earlier for Q3 2025, Monday.com achieved total revenue of $317 million, which was a 26% increase year-over-year. This revenue was also $4.59 million above Street expectations. EPS for the quarter stood at $1.16, which surpassed guidance by $0.28. The company also maintained strong customer loyalty, with Net Dollar Retention at 111% in Q3, a rate expected to remain stable for the entire 2025.
The multi-product strategy is successfully driving growth, with new products now accounting for over 10% of total ARR, which surpassed the company’s 2025 goal ahead of schedule. However, the company’s guidance for the upcoming quarter reflects a more measured approach, sparking some concern over future growth. Q4 revenue guidance is projected to be between $328 and $330 million, which translates to a lower growth of 22% to 23%. Full-year 2025 revenue guidance was set at $1.226 to $1.228 billion, a ~26% growth.
Monday.com Ltd. (NASDAQ:MNDY) develops software applications internationally. The company provides Work Operating System, a cloud-based visual work OS that consists of modular building blocks used to assemble software applications and work management tools.
4. HubSpot Inc. (NYSE:HUBS)
Number of Hedge Fund Holders: 124
Average Upside Potential as of November 25: 84.91%
HubSpot Inc. (NYSE:HUBS) is one of the most promising stocks with huge upside potential. On November 9, Truist analyst Terry Tillman lowered the price target on HubSpot to $650 from $675 with a Buy rating on the shares. Tillman noted that the company posted a robust Q3 2025, outperforming the firm’s revenue and earnings estimates, thanks to consistent growth and margin discipline.
In the quarter, HubSpot delivered solid performance with revenue reaching $810 million, which marked an 18.4% increase year-over-year. Subscription revenue alone grew by 21% year-over-year, while Services & Other revenue increased by 19%.
HubSpot was able to expand its customer base in Q3, adding 10,900 new customers, bringing the total customer count to ~279,000. The company’s multi-hub adoption strategy is proving effective, with 43% of the Pro+ installed base by ARR subscribing to three core hubs. HubSpot provided guidance for Q4 and the full year 2025. Q4 revenue guidance is now set at $828 to $830 million, representing growth of 16% year-over-year.
HubSpot Inc. (NYSE:HUBS) provides a cloud-based customer relationship management/CRM platform for businesses in the Americas, Europe, and the Asia Pacific.
3. Oracle Corporation (NYSE:ORCL)
Number of Hedge Fund Holders: 124
Average Upside Potential as of November 25: 84.91%
Oracle Corporation (NYSE:ORCL) is one of the most promising stocks with huge upside potential. On November 25, DA Davidson lowered the firm’s price target on Oracle to $200 from $300 with a Neutral rating on the shares. The firm noted that when Oracle reported earnings for FQ1 2026, the company initially suggested that the increase in Remaining Performance Obligations/RPO was driven by several customers. However, the following day, it was revealed that nearly the entire RPO increase was attributable to a single customer: OpenAI.
Although the $300 billion commitment was OpenAI’s largest at the time, making Oracle appear to have won a significant deal, the firm argues that OpenAI’s subsequent announcement of over a trillion dollars in commitments showed that it was not a serious counterpart and had effectively used Oracle as a pawn in a grand strategy of self-promotion.
In the company’s FQ1 2026 earnings report, Oracle disclosed that it made $14.9 billion in total revenue, which was an 11% increase from the previous year. This performance was propelled by massive AI demand, leading to a huge acceleration in Oracle’s backlog. RPO reached an all-time high of $455 billion, which marked a huge 359% increase year-over-year. The company is aggressively pursuing the even larger AI inferencing market, using its position as the largest custodian of high-value private enterprise data.
Oracle Corporation (NYSE:ORCL) offers products and services that address enterprise information technology environments worldwide.
2. Syndax Pharmaceuticals Inc. (NASDAQ:SNDX)
Number of Hedge Fund Holders: 53
Average Upside Potential as of November 25: 105.66%
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the most promising stocks with huge upside potential. On November 24, Barclays raised the firm’s price target on Syndax to $35 from $22, while maintaining an Overweight rating on the shares. The firm’s sentiment followed an overall update on the company’s model after speaking with management.
Earlier the same month, Syndax Pharmaceuticals also released its Q3 2025 earnings report, where the company disclosed that it achieved total revenue of $45.9 million, which was a 21% sequential growth propelled by two key medicines: Revvvi Forge and Nick Timbo, both characterized as first and best-in-class therapies. The company’s commercial strategy is showing success with strong patient uptake and sustained growth potential for both products.
Nick Timbo alone saw a net revenue increase of 27% over the prior quarter and is annualizing at ~$200 million. Revvvi Forge is rapidly expanding its addressable market following its FDA approval for relapse-refractory NPM1-mutated AML, in addition to its initial KMT2A-rearranged acute leukemia indication. Its position in the treatment landscape was further solidified by its addition to the NCCN guidelines.
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is a commercial-stage biopharmaceutical company that develops therapies for the treatment of cancer.
1. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
Number of Hedge Fund Holders: 60
Average Upside Potential as of November 25: 140.12%
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the most promising stocks with huge upside potential. On November 24, Barclays analyst Gena Wang lowered the firm’s price target on Ultragenyx (RARE) to $50 from $81 and maintained an Overweight rating on the shares. The firm lowered its price target following analysis of the setrusumab COSMIC study, but still maintains an over 70% chance of a positive result.
Earlier the same month, Ultragenyx Pharmaceutical reported that it made a total revenue of $160 million in Q3 2025, which marked a 15% growth year-over-year. The company is now on track to deliver full-year revenue between $640 and $670 million, which represents a growth of 14% to 20% over 2024. Revenue growth was driven by its key commercial products. Crysvita Revenue accounted for $112 million in Q3. The full-year Crysvita revenue guidance is expected between $460 and $480 million, a 12% to 17% growth over 2024, despite the short-term impact from expected seasonality on royalty revenue. AJOVY Revenue for the quarter was $24 million, and Mepsevii Revenue was $7 million.
The company also reported a net loss of $180 million or $1.81 per share for Q3. Ultragenyx is now aggressively advancing multiple late-stage clinical programs with transformative commercial potential, including UX 143 (setrusumab) and GTX-102. Submissions for other pipeline assets are also on track, with DTX401 expected for submission next month, while the submission for UX 111 was slightly delayed due to requirements for additional reports.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is a biopharmaceutical company that identifies, acquires, develops, and commercializes novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.
While we acknowledge the potential of RARE to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than RARE and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
